Our policy in the Medical Programs Department of the National Psoriasis Foundation (NPF) is to ensure balance, independence, objectivity, and scientific rigor in all our educational programs.  Anyone presenting or participating in the planning of any NPF CME programs is expected to disclose to the Medical Programs Department any real or apparent affiliation(s) within the past 12 months that may have a direct bearing on the subject matter of the continuing medical education program.  The intent of this policy is to ensure continuing medical education programs that are free of commercial interests.

The following faculty and planning committee have disclosed the following relationships with commercial interests:


Joseph Merola, MD, MMSc
Dr. Merola is a consultant and/or investigator for Merck Research Laboratories, AbbVie, Dermavant, Eli Lilly and Company, Novartis, Janssen, UCB, Samumed, Celgene, Sanofi, Regeneron, GSK, Almirall, Sun Pharma, Biogen, Pfizer, Incyte, Aclaris, and Leo Pharma.

Medical Board: National Psoriasis Foundation.

Steering Committee: GRAPPA

Board of Directors: IDEOM (International Dermatology Outcome Measures), PPACMAN (Psoriasis and Psoriatic Arthritis Multicenter Advancement Network)

Expert Panel: ACR PsA Guidelines

Emily Baumrin, MD

No relevant financial relationships with any commercial interests.

Planning Committee:

Andi Agnew has disclosed no relevant financial relationships with any commercial interests.